Furthermore, the selected compound (Figure 7C) exhibits an antiproliferative effect in mantle cell lymphoma cell lines (Granta-519 cells treated with 1 μM PROTAC from Figure 7C for 1 d resulted in the loss of CDK4/6) [109]. This evidence concerns the gene CDK4 and mantle cell lymphoma.